Sort
82,697 grants matching “vaccine development”
Chikungunya Recombinant Subunit Vaccine
$1,000,000David E. Clements · Hawaii Biotech, Inc. · R44 · FY2021 · AI
A Vaccine for Lymphatic Filariasis, LFGuardâ¢
$1,000,000Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2020 · AI
Development of VLP vaccine for RSV
$1,000,000Jorge C Blanco · Sigmovir Biosystems, Inc. · R44 · FY2021 · AI
A Cytomegalovirus-based therapeutic vaccine for chronic hepatitis B
$1,000,000Eric Bruening · Tomegavax, Inc. · R44 · FY2019 · AI
Identification of Novel Broad Spectrum Influenza Virus Inhibitors
$1,000,000Arnab Basu · Microbiotix, Inc · R44 · FY2012 · AI
Delivery system development for a reservoir targeted Lyme disease vaccine
$1,000,000Linden T Hu · Foodsource Lure Corporation · R42 · FY2014 · AI
Experimental Gonococcal Vaccine
$1,000,000Dominick Auci · Therapyx, Inc. · R44 · FY2021 · AI
OTHER FUNCTIONS R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH), MULTI-BIOMARKER IMAGI
$1,000,000Ocean Nanotech, Llc · N44 · FY2012 · CA
Enhanced Surveillance for Newly Preventable Diseases (ARI and AGE Surveillance) - Rochester, NY
$1,000,000Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2019 · IP
New Vaccine Surveillance Network SUPPLEMENT
$1,000,000John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · IP
MR191_ An Immunoprotectant for Marburg Virus
$1,000,000Ronald T Aimes · Mapp Biopharmaceutical, Inc. · SB1 · FY2019 · AI
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
$1,000,000Mark E McDonnell · Fox Chase Chemical Diversity Center, Inc · R44 · FY2024 · AI
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$1,000,000Paul Joseph Utz · Stanford University · R01 · FY2019 · AI
Treatment of Inflammatory Complications of Respiratory Infection
$1,000,000Michael William Lark · Respana Therapeutics, Inc. · R42 · FY2024 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2021 · AI
Respiratory Virus Vaccine and Adjuvant Exploration
$1,000,000Ralph S Baric · Univ Of North Carolina Chapel Hill · U01 · FY2021 · AI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine
$1,000,000Kenneth C Bagley · Orlance, Inc. · R44 · FY2020 · AI
Bunyavirus biology, immunity, and countermeasure development
$1,000,000Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain
$1,000,000Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2020 · AI
Non-Human Primate Lymphoid Organ Chips for Vaccine Assessment
$1,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
Respiratory Virus Vaccine and Adjuvant Exploration
$1,000,000Ralph S Baric · Univ Of North Carolina Chapel Hill · U01 · FY2020 · AI
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa
$1,000,000Christopher Fisher · Nanovir, Llc. · R42 · FY2011 · AI
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
$1,000,000Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
MR191_ An Immunoprotectant for Marburg Virus
$1,000,000Ronald T Aimes · Mapp Biopharmaceutical, Inc. · SB1 · FY2017 · AI
Pre-Clinical HPV16 Antiviral Compound Development
$1,000,000Christopher Fisher · Nanovir, Llc. · R42 · FY2008 · AI